Ψ-DODFMO

Ψ-DODFMO, also known as 4-difluoromethoxy-2,6-dimethoxyamphetamine, is a psychedelic drug of the phenethylamine, amphetamine, and ψ-phenethylamine families.^[2][1] It is the amphetamine (α-methyl) analogue of ψ-2C-DFMO and is also structurally related to other psychedelics like difluoromescaline (DFM) and 2C-T-35 (2C-T-DFM).^[2][1] The drug has been found to be active at a dose of 5 mg plus 5 mg (or 10 mg total) orally, with moderately intense effects and a relatively long duration of around 20 hours.^[2][1] Ψ-DODFMO was first described in the scientific literature by Daniel Trachsel in 2012.^[2][1]

Ψ-DODFMO

Clinical data
Other names	4-Difluoromethoxy-2,6-dimethoxyamphetamine
Routes of administration	Oral[1]
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None
Pharmacokinetic data
Duration of action	~20 hours[1]
Identifiers
IUPAC name 1-[4-(difluoromethoxy)-2,6-dimethoxyphenyl]propan-2-amine
Chemical and physical data
Formula	C12H17F2NO3
Molar mass	261.269 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1cc(OC(F)F)cc(c1CC(N)C)OC
InChI InChI=1S/C12H17F2NO3/c1-7(15)4-9-10(16-2)5-8(18-12(13)14)6-11(9)17-3/h5-7,12H,4,15H2,1-3H3 Key:XEJQGOZXVLCLQY-UHFFFAOYSA-N

See also

• ψ-Phenethylamine
• Ψ-2C-DFMO
• Difluoromescaline (DFM)
• 2C-T-35 (2C-T-DFM)